How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Coextruded Medical Tube Market
- By Material Type: Polyvinyl Chloride (PVC), Polyethylene (PE), Polyurethane (PU), Thermoplastic Elastomers (TPE), Fluoropolymers
- By End-Use Application: Intravenous (IV) Therapy, Catheters, Surgical Drainage, Blood Collection, Respiratory Devices
- By Tube Structure: Single-Lumen Tubes, Multi-Lumen Tubes, Reinforced Tubes, Braided Tubes
- By Manufacturing Technology: Coextrusion, Extrusion with Coating, Injection Molding with Coextrusion
- By Product Feature: Sterile Tubes, Non-Sterile Tubes, Radiopaque Tubes, Antimicrobial Tubes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Polyvinyl Chloride (PVC) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Coextruded Medical Tube Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
End-Use Application 5
Tube Structure 4
Manufacturing Technology 3
Product Feature 4
Companies profiled
Saint-Gobain
Freudenberg Medical
B. Braun Melsungen AG
Teleflex Incorporated
Nipro Corporation
Smiths Medical
Terumo Corporation
Hollister Incorporated
Medtronic
Becton Dickinson and Company (BD)
C. R. Bard (now part of BD)
Parker Hannifin Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Saint-Gobain
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Freudenberg Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Smiths Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Terumo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Hollister Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Medtronic
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Becton Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →C. R. Bard (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Parker Hannifin Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Avery Dennison Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nordson Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →BASF SE
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$7,271M by 2033 · 5.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polyvinyl Chloride (PVC)42.2
- Polyethylene (PE)17.0
- Polyurethane (PU)13.5
- Thermoplastic Elastomers (TPE)17.8
- Fluoropolymers9.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,619M → $2,203M · 3.9%
Europe$1,128M → $1,860M · 6.5%
Asia Pacific$1,030M → $1,393M · 3.8%
Latin America$637.6M → $893.6M · 4.3%
Middle East and Africa$490.5M → $798.5M · 6.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.992026
5.002027
5.022028
5.042029
5.042030
5.052031
5.072032
5.082033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Saint-Gobain22.2
- Freudenberg Medical20.4
- B. Braun Melsungen AG7.7
- Teleflex Incorporated9.6
- Nipro Corporation6.2
- Smiths Medical5.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type21.6%
End-Use Application27.6%
Tube Structure15.5%
Manufacturing Technology8.1%
Product Feature27.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.8
- Europe26.0
- Asia Pacific19.5
- Latin America12.5
- Middle East and Africa11.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Saint-Gobain | 88 | 76 | 95 | 82 | 81 | 92 | 86 |
| Freudenberg Medical | 80 | 76 | 78 | 70 | 92 | 73 | 78 |
| B. Braun Melsungen AG | 80 | 63 | 77 | 64 | 72 | 63 | 70 |
| Teleflex Incorporated | 66 | 64 | 62 | 76 | 66 | 57 | 65 |
| Nipro Corporation | 60 | 62 | 59 | 52 | 68 | 56 | 60 |
| Smiths Medical | 71 | 60 | 48 | 71 | 48 | 62 | 60 |
| Terumo Corporation | 44 | 66 | 45 | 48 | 41 | 49 | 49 |
| Hollister Incorporated | 45 | 53 | 37 | 54 | 42 | 43 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Saint-Gobain
- Freudenberg Medical
- B. Braun Melsungen AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Saint-Gobain | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Freudenberg Medical | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| B. Braun Melsungen AG | ✓ | − | ◐ | − | ✓ | ◐ |
| Teleflex Incorporated | − | ◐ | − | ◐ | ◐ | − |
| Nipro Corporation | − | ✓ | − | ◐ | ◐ | ◐ |
| Smiths Medical | − | − | − | ✓ | − | ◐ |
| Terumo Corporation | − | ✓ | − | − | − | − |
| Hollister Incorporated | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Saint-Gobain86
2Freudenberg Medical78
3B. Braun Melsungen AG70
4Teleflex Incorporated65
5Nipro Corporation60
6Smiths Medical60
7Terumo Corporation49
8Hollister Incorporated46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Saint-GobainFreudenberg Medical
Challenger1
Strong scale, closing on the leaders.
B. Braun Melsungen AG
Contender3
Focused players with pockets of strength.
Teleflex IncorporatedNipro CorporationSmiths Medical
Niche2
Specialists in a single segment or region.
Terumo CorporationHollister Incorporated
Go-to-market strategy
Land Material Type in North America, then scale across Coextruded Medical Tube Market — a $183M beachhead inside a $2.45B market.
Beachhead (SOM)$183Mobtainable near-term
Serviceable (SAM)$991Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Polyvinyl Chloride (PVC)
Best fit — highest urgency & budget in Material Type.
Economic buyer79 fit
Polyethylene (PE)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Polyurethane (PU)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-Use Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Tube Structure
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel28%
Digital / self-serve18%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Coextruded Medical Tube Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified20%
Evaluation12%
Closed-won7%
$15.6KCAC
$91KLTV
5.8:1LTV : CAC
< 3 moCAC payback
Investment thesis
Coextruded Medical Tube Market is a durable-growth opportunity — $6.24B by 2033, compounding at 8.6%.
TAM · 2025$3.22Btoday
TAM · 2033$6.24Bforecast
CAGR8.6%2027–2033
Cumulative$41.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.24BTotal addressable market
SAM$2.23BServiceable available market
SOM$397MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.24BLarge & growingTAM by 2033 at 8.6% CAGR
$2.23BServiceable nowreachable with today’s model
$397MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.87BBear5.6% CAGR
$6.24BBase8.6% CAGR
$7.99BBull11.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-Use Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Coextruded Medical Tube Market — a $10.1B market by 2033. Plan: grow share from 10.2% to 17.4%.
Market size · 2033$10.1Btotal addressable
Market CAGR8.7%2027–2033
Target share17.4%from 10.2% today
Revenue ambition$1.76Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.2% | 17.4% | Ahead |
| Revenue | $964M | $1.76B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.6% | 41.2% | At risk |
| Customer retention | 91.3% | 95.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-Use Application capability
A defensible second engine — invest in End-Use Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-Use Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $256M capacity & capability investment
- Greenlight bolt-on M&A in End-Use Application
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Sales deck · value proposition
Win the Coextruded Medical Tube Market conversation — a $6.98B market you can size, segment and defend in minutes.
Market size · 2033$6.98Btotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers1,284+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 4 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Saint-GobainFreudenberg MedicalB. Braun Melsungen AGTeleflex IncorporatedNipro CorporationSmiths MedicalTerumo CorporationHollister Incorporated+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Coextruded Medical Tube Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Coextruded Medical Tube Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Coronary Guidewire Market
Market size, share, segmentation and regional forecast.
$672M by 2033 · 6.05% CAGR
View reportLight Sources For Endoscope Market
Market size, share, segmentation and regional forecast.
$14.3B by 2033 · 8.79% CAGR
View reportOphthalmic Diagnostic Device Market
Market size, share, segmentation and regional forecast.
$12.2B by 2031 · 4.49% CAGR
View reportOphthalmic Operating Microscope Market
Market size, share, segmentation and regional forecast.
$2.1B by 2031 · 5.80% CAGR
View reportOphthalmic Ultrasound Device Market
Market size, share, segmentation and regional forecast.
$12.6B by 2032 · 3.34% CAGR
View reportOphthalmic Viscoelastic Devices (OVDs) Market
Market size, share, segmentation and regional forecast.
$619M by 2032 · 3.23% CAGR
View reportOphthalmic Viscosurgical Devices (OVD) Market
Market size, share, segmentation and regional forecast.
$12.8B by 2033 · 7.44% CAGR
View reportPeripheral Stent Graft Market
Market size, share, segmentation and regional forecast.
$9.0B by 2033 · 5.79% CAGR
View reportPositron Emission tomography (Pet) Scanners Market
Market size, share, segmentation and regional forecast.
$6.4B by 2031 · 10.40% CAGR
View reportSurgical Adhesion Barriers Market
Market size, share, segmentation and regional forecast.
$9.1B by 2031 · 9.73% CAGR
View reportSurgical hook Market
Market size, share, segmentation and regional forecast.
$8.8B by 2031 · 7.94% CAGR
View reportProphylactic Human Vaccine Market
Market size, share, segmentation and regional forecast.
$3.6B by 2031 · 8.08% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.